Dr Jan Wren joins SafeBridge Europe

Brings more than 20 years' experience at GSK to the position

Jan Wren has joined SafeBridge as Senior Occupational Hygienist reporting to the SafeBridge Europe office in Liverpool, UK.

Wren has more than 20 years of experience at GlaxoSmithKline in the UK where she occupied a senior role as Environmental Health and Safety (EHS) Director, EHS Business Lead for GSK Research and Development and Global Franchises. She is an expert in Occupational Hygiene and is a Chartered Fellow of the Faculty of Occupational Hygiene in the British Occupational Hygiene Society (BOHS).

Wren's health and safety skills span the industry, bringing strengths in risk management, occupational hygiene, process safety, environmental management, emergency response and other core skills to the SafeBridge team.

She will be working with clients in developing and promoting occupational hygiene capability and related technical and management services.

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Training & Education

Evaluation and safe handling of ADCs and their toxic payloads: Part 2

In this second article of a two-part series, John Farris, CIH, and Robert Sussman, PhD DABT, SafeBridge Consultants, cover the safe handling of antibody-drug conjugates in pharmaceutical facilities and the control measures needed to protect workers from exposure risks
Regulatory

SafeBridge to merge with Trinity Consultants

Trinity Consultants plans to provide the resources to expand SafeBridge
Manufacturing

SafeBridge certifies Baxter facilities in Germany

For the safe handling of potent pharmaceutical compounds at Halle and Bielefeld
Manufacturing

SafeBridge certifies Excella HPAPI plant in Germany

Meets potent compound safety certification standard
Manufacturing

SafeBridge offers improved sensitivity for naproxen sodium analysis

SafeBridge Consultants\' industrial hygiene analytical laboratory has validated an air sampling process with improved analytical sensitivity for the measurement of naproxen sodium on filters.
Containment

Handling potent drug materials

Drug manufacturer Hovione has opened a new spray drying facility in Loures, Portugal, for potent active ingredients. Marco Marques, head of production, describes the safety protocols
Regulatory

Overcoming CMC challenges in cell and gene therapy: part I

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Subscribe now